IT Brief India - Technology news for CIOs & IT decision-makers
Story image

Innominds featured in Microsoft's AI Coffee Table Book

Today

Innominds has been honoured with a feature in Microsoft's AI-centric Coffee Table Book, 'From Promise to Proof'.

The book showcases 200 companies at the forefront of AI innovation, highlighting how these firms are utilising artificial intelligence to transform their businesses. Innominds' AI-driven solution, AMRx, which incorporates Microsoft Azure AI technologies, is one of the solutions spotlighted in this publication.

AMRx is an AI/ML-powered digital diagnostic tool developed by Innominds in collaboration with SCIINV Biosciences. It was designed to address antimicrobial resistance (AMR), a growing concern in the healthcare industry.

Divakar Tantravahi, Chief Executive Officer of Innominds, commented on the recognition, "We are honoured to be selected by Microsoft for this unique initiative. This recognition underscores our commitment to harnessing AI and emerging technologies to drive meaningful outcomes for our customers. Our collaboration with Microsoft has enabled us to deliver world-class solutions that make a difference."

Dr Ranga Reddy, Scientific Advisor at SCIINV Biosciences, also shared his thoughts on the diagnostic tool, "AI-based diagnostic tools represent a breakthrough in the fight against antimicrobial resistance, addressing critical gaps in laboratory infrastructure and workforce capacity. AMRx, a pioneering, culture-free, patented diagnostic solution, harnesses advanced AI/ML algorithms to predict Urinary Tract Infections and identify antibiotic resistance patterns using patient clinical history. This cutting-edge innovation bridges laboratory capacity limitations and significantly enhances precision in infectious disease management."

The inclusion of Innominds in the AI Coffee Table Book highlights its ongoing efforts in AI applications and its partnership with Microsoft to develop impactful digital solutions. The AMRx tool represents a significant advancement in digital diagnostics, specifically targeting the threat of antimicrobial resistance through innovative solutions.

Follow us on:
Follow us on LinkedIn Follow us on X
Share on:
Share on LinkedIn Share on X